We previously studied the clinical and pathological characteristics of a cohort of patients with Alzheimer’s disease and found a marked heterogeneity of tau seeding in this same biosensor line which was associated both with specific molecular characteristics of tau oligomers as well as differences in clinical disease progression.17 Here, MAPT is linked to Alzheimer disease.